These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 32675393)
1. lncRNA GAS8-AS1 genetic alterations in papillary thyroid carcinoma and their clinical significance. Zhou DL; Liu Q; Xu BH; Li Y; Su X; Ye ZL; Zhang X; Peng JL; Deng L; Tang T; Shao Q; Ma JJ; Yang XH; He CY Cancer Biomark; 2020; 29(2):255-264. PubMed ID: 32675393 [TBL] [Abstract][Full Text] [Related]
2. Whole exome sequencing identifies lncRNA GAS8-AS1 and LPAR4 as novel papillary thyroid carcinoma driver alternations. Pan W; Zhou L; Ge M; Zhang B; Yang X; Xiong X; Fu G; Zhang J; Nie X; Li H; Tang X; Wei J; Shao M; Zheng J; Yuan Q; Tan W; Wu C; Yang M; Lin D Hum Mol Genet; 2016 May; 25(9):1875-84. PubMed ID: 26941397 [TBL] [Abstract][Full Text] [Related]
5. Altered expression of DLG1-AS1 distinguished papillary thyroid carcinoma from benign thyroid nodules. He T; Wang H; Sun J; Wu J; Gong F; Li S; Wang H; Li Y BMC Endocr Disord; 2019 Nov; 19(1):122. PubMed ID: 31718630 [TBL] [Abstract][Full Text] [Related]
6. STAT3-induced upregulation of lncRNA ABHD11-AS1 promotes tumour progression in papillary thyroid carcinoma by regulating miR-1301-3p/STAT3 axis and PI3K/AKT signalling pathway. Wen J; Wang H; Dong T; Gan P; Fang H; Wu S; Li J; Zhang Y; Du R; Zhu Q Cell Prolif; 2019 Mar; 52(2):e12569. PubMed ID: 30657221 [TBL] [Abstract][Full Text] [Related]
7. LncRNA GAS8-AS1 inhibits cell proliferation through ATG5-mediated autophagy in papillary thyroid cancer. Qin Y; Sun W; Zhang H; Zhang P; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang W; Wu C Endocrine; 2018 Mar; 59(3):555-564. PubMed ID: 29327301 [TBL] [Abstract][Full Text] [Related]
8. Upregulation of long noncoding RNA MALAT1 in papillary thyroid cancer and its diagnostic value. Liu J; Dong H; Yang Y; Qian Y; Liu J; Li Z; Guan H; Chen Z; Li C; Zhang K; Zhang Q; Cao W; Lv J Future Oncol; 2018 Dec; 14(29):3015-3022. PubMed ID: 29987950 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of serum lncRNA-ABHD11-AS1 as poor prognosis of patients with papillary thyroid carcinoma. Hou S; Zhuang YY; Lin QY; Chen Z; Zhao HG; Zhang L; Lin CH Exp Mol Pathol; 2021 Aug; 121():104658. PubMed ID: 34102210 [TBL] [Abstract][Full Text] [Related]
10. RET/PTC Rearrangements Are Associated with Elevated Postoperative TSH Levels and Multifocal Lesions in Papillary Thyroid Cancer without Concomitant Thyroid Benign Disease. Su X; He C; Ma J; Tang T; Zhang X; Ye Z; Long Y; Shao Q; Shao J; Yang A PLoS One; 2016; 11(11):e0165596. PubMed ID: 27802347 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA TTN-AS1 facilitates tumorigenesis of papillary thyroid cancer through modulating the miR-153-3p/ZNRF2 axis. Cui Z; Luo Z; Lin Z; Shi L; Hong Y; Yan C J Gene Med; 2019 May; 21(5):e3083. PubMed ID: 30811764 [TBL] [Abstract][Full Text] [Related]
12. Plasma lncRNA GAS8-AS1 as a Potential Biomarker of Papillary Thyroid Carcinoma in Chinese Patients. Zhang D; Liu X; Wei B; Qiao G; Jiang T; Chen Z Int J Endocrinol; 2017; 2017():2645904. PubMed ID: 28781594 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma. Feng Z; Chen R; Huang N; Luo C Life Sci; 2020 Mar; 244():117298. PubMed ID: 31953163 [TBL] [Abstract][Full Text] [Related]
14. ATF2-Induced lncRNA GAS8-AS1 Promotes Autophagy of Thyroid Cancer Cells by Targeting the miR-187-3p/ATG5 and miR-1343-3p/ATG7 Axes. Qin Y; Sun W; Wang Z; Dong W; He L; Zhang T; Shao L; Zhang H Mol Ther Nucleic Acids; 2020 Dec; 22():584-600. PubMed ID: 33230459 [TBL] [Abstract][Full Text] [Related]
15. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer. Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600 [TBL] [Abstract][Full Text] [Related]
16. CCNA1 gene as a potential diagnostic marker in papillary thyroid cancer. da Silva RM; Santos JN; Uno M; Chammas R; Kulcsar MAV; Sant'Anna LB; Canevari RA Acta Histochem; 2020 Dec; 122(8):151635. PubMed ID: 33007517 [TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA CASC9 promotes the proliferation and metastasis of papillary thyroid cancer via sponging miR-488-3p. Chen Y; Li Y; Gao H Cancer Med; 2020 Mar; 9(5):1830-1841. PubMed ID: 31943867 [TBL] [Abstract][Full Text] [Related]
18. Effect of thyroidectomy on circulating angiogenic cytokines in papillary thyroid carcinoma and benign goiter: Potential for new biomarkers? Ria R; Prete F; Melaccio A; Di Meo G; Saltarella I; Solimando AG; Gurrado A; Ferraro V; Pasculli A; Sgaramella LI; Racanelli V; Vacca A; Testini M Surgery; 2021 Jan; 169(1):27-33. PubMed ID: 32482341 [TBL] [Abstract][Full Text] [Related]
19. Correlations of HOTAIR expression with pathological stage, CT characteristics and prognosis of patients with papillary thyroid carcinoma. Chen X; Jin J; Zheng L; Sheng Y; Sun J J BUON; 2021; 26(1):259-265. PubMed ID: 33721460 [TBL] [Abstract][Full Text] [Related]
20. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma. Zhang Z; Li SY; Zhang LB Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]